©The Author(s) 2026.
World J Gastroenterol. Jan 28, 2026; 32(4): 114420
Published online Jan 28, 2026. doi: 10.3748/wjg.v32.i4.114420
Published online Jan 28, 2026. doi: 10.3748/wjg.v32.i4.114420
Figure 7 The migration and invasion of HepG2 tested by Transwell in each group.
A: The picture of migration and invasion. The migration and invasion of HepG2 showed best result in the group of 25 nmol/L triptolide combined 100 μmol/L quercetin; B: The numbers of migrational cell. It showed the combinational group had statistically significant difference compared with other groups after 12 hours treatment; C: The numbers of invasional cell. The combinational group had statistically significant difference compared with control group and quercetin group after 24 hours treatment, meanwhile the P value is low compared to triptolide (P = 0.058). The tests were performed at least three independent parallel experiments. Data was presented as means ± SE of three independent experiments. aP < 0.05. TP: Triptolide; QU: Quercetin.
- Citation: Tong HX, Zhang JL, Nie WY, Jiang LJ, Hu JQ, Lu T. Synergistic anti-hepatoma effect of triptolide and quercetin via co-inhibition and interaction with Janus kinase and mammalian target of rapamycin signal pathway. World J Gastroenterol 2026; 32(4): 114420
- URL: https://www.wjgnet.com/1007-9327/full/v32/i4/114420.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i4.114420